Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Cymabay Therapeutics (CBAY)

7.8112 -0.1788 (-2.2378%)

7/27/2017  2:35pm

Open:

8.0000

Pre. Close:

7.9900

High:

8.2909

Low:

7.6500

Volume:

1,203,401

Market Cap:

224.59M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

8.41 - 8.56

8.56 - 8.65

Low:

7.38 - 7.53

7.53 - 7.61

Close:

7.88 - 8.12

8.12 - 8.25

Technical analysis  (as of: 2017-07-27 2:06:17 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 9.68     One year: 11.31

Support:

Support1: 6.26    Support2: 5.00

Resistance:

Resistance1: 8.29    Resistance2: 9.68

Pivot:

6.72

Moving Averages:

MA(5): 7.89     MA(20): 6.47

MA(100): 4.62     MA(250): 3.07

MACD:

MACD(12,26): 0.77     Signal(12,26,9): 0.61

%K %D:

%K(14,3): 91.69     %D(3): 93.09

RSI:

RSI(14): 78.09

52-Week:

High: 8.2909  Low: 1.1500  Change(%): 314.9

Average Vol(K):

3-Month: 85702  10-Days 324160

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CBAY has closed below upper band by 22.5%. Bollinger Bands are 244.7% wider than normal. The large width of the bands suggest high volatility as compared to CBAY's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

Thu, 13 Jul 2017 11:37:30 GMT
Implied Volatility Surging for Cymabay Therapeutics (CBAY) Stock Options

Wed, 19 Jul 2017 14:36:57 GMT
Can CymaBay Therapeutics Inc (NASDAQ:CBAY) Continue On Its Superb Run?

Mon, 17 Jul 2017 11:26:15 GMT
Cymabay Therapeutics (CBAY) Catches Eye: Stock Gains 6.2% July 20, 2017

Thu, 27 Jul 2017 18:33:45 GMT
CymaBay Therapeutics' (NASDAQ:CBAY) Overweight Rating Reaffirmed at Piper ...

Thu, 27 Jul 2017 17:37:30 GMT
The Dirty Secret to Trading Atkore International Group Inc. (ATKR), Cymabay ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

28.75

Shares Float (M)

24.94

% Held by Insiders

5.27

% Held by Institutions

30.00

Shares Short (K)

721

Shares Short Prior Month (K)

753

Stock Financials

EPS

-1.040

EPS Est. Current Year

-0.830

EPS Est. Next Year

-0.680

EPS Est. Next Quarter

-0.190

Forward EPS

-0.680

Book Value (p.s.)

0.320

PEG Ratio

Profit Margin

Operating Margin

-426.58

Return on Assets (ttm)

-41.1

Return on Equity (ttm)

-162.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.710

Qtrly Earnings Growth

Operating Cash Flow (M)

-19.42

Levered Free Cash Flow (M)

-7.36

FoxReading.com

Valuation

P/E

-7.54

P/E Growth Ratio

-0.02

P/BV

24.51

P/S

1127273088.00

P/CF

-11.61

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.